Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tze Leung Lai, Michael Sklar & Nikolas Thomas Weissmueller. (2021) Novel Clinical Trial Designs and Statistical Methods in the Era of Precision Medicine. Statistics in Biopharmaceutical Research 13:2, pages 133-146.
Read now
Read now
Articles from other publishers (21)
Deepak Parashar. (2023) Unlocking multidimensional cancer therapeutics using geometric data science. Scientific Reports 13:1.
Crossref
Crossref
Asma AqibBertrand LebouchéKim Engler & Tibor Schuster. (2023) Feasibility of a Platform Trial Design for the Development of Mobile Health Applications: A Review. Telemedicine and e-Health 29:4, pages 501-509.
Crossref
Crossref
Karolina Strzebonska, Mateusz Blukacz, Mateusz T. Wasylewski, Maciej Polak, Bishal Gyawali & Marcin Waligora. (2022) Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis. BMC Medicine 20:1.
Crossref
Crossref
Haiyan Zheng & James M S Wason. (2022) Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy. Biostatistics 23:1, pages 120-135.
Crossref
Crossref
Hina Saeed & Issam El Naqa. 2022. Machine and Deep Learning in Oncology, Medical Physics and Radiology. Machine and Deep Learning in Oncology, Medical Physics and Radiology
453
501
.
Wanying Zhao, Wei Ma, Fan Wang & Feifang Hu. (2021) Incorporating covariates information in adaptive clinical trials for precision medicine. Pharmaceutical Statistics 21:1, pages 176-195.
Crossref
Crossref
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson & Stephen Palmer. (2021) Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technology Assessment 25:76, pages 1-228.
Crossref
Crossref
Masturah Bte Mohd Abdul Rashid. (2021) Artificial Intelligence Effecting a Paradigm Shift in Drug Development. SLAS Technology 26:1, pages 3-15.
Crossref
Crossref
Peter Murphy, Lindsay Claxton, Robert Hodgson, David Glynn, Lucy Beresford, Matthew Walton, Alexis Llewellyn, Stephen Palmer & Sofia Dias. (2021) Exploring Heterogeneity in Histology-Independent Technologies and the Implications for Cost-Effectiveness. Medical Decision Making 41:2, pages 165-178.
Crossref
Crossref
Christian Dittrich, Lutz Edler & Herbert Sindermann. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
53
.
Christian Dittrich. (2020) Basket trials: From tumour gnostic to tumour agnostic drug development. Cancer Treatment Reviews 90, pages 102082.
Crossref
Crossref
Adam C. Palmer, Deborah Plana & Peter K. Sorger. (2020) Comparing the Efficacy of Cancer Therapies between Subgroups in Basket Trials. Cell Systems 11:5, pages 449-460.e2.
Crossref
Crossref
Andrew R. Exley, Khadija Rantell & James McBlane. (2020) Clinical development of cell therapies for cancer: The regulators' perspective. European Journal of Cancer 138, pages 41-53.
Crossref
Crossref
Ming-Wen An, Quyen Duong, Jennifer Le-Rademacher & Sumithra J. Mandrekar. (2020) Principles of Good Clinical Trial Design. Journal of Thoracic Oncology 15:8, pages 1277-1280.
Crossref
Crossref
Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, Hans-Jürgen Fülle, Ekkehard Glimm, Yuhan Li, Martin Posch & Franz König. (2020) The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review. Clinical Therapeutics 42:7, pages 1330-1360.
Crossref
Crossref
Olivier Collignon, Christian Gartner, Anna‐Bettina Haidich, Robert James Hemmings, Benjamin Hofner, Frank Pétavy, Martin Posch, Khadija Rantell, Kit Roes & Anja Schiel. (2020) Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials. Clinical Pharmacology & Therapeutics 107:5, pages 1059-1067.
Crossref
Crossref
Andriy Krendyukov & Sreekanth Gattu. (2020) Critical Factors Shaping Strategy Development of an Innovative Medicine in Oncology. Pharmaceutical Medicine 34:2, pages 103-112.
Crossref
Crossref
Sarah P. Blagden, Lucinda Billingham, Louise C. Brown, Sean W. Buckland, Alison M. Cooper, Stephanie Ellis, Wendy Fisher, Helen Hughes, Debbie A. Keatley, Francois M. Maignen, Alex Morozov, Will Navaie, Sarah Pearson, Abeer Shaaban, Kirsty Wydenbach, Pamela R. Kearns, Christiane Abouzeid, Rubina Ahmed, Sue Bailey, Catherine Blewett, Helen Campbell, Maria Antonietta Cerone, Glen Clack, Natalie Cook, Serban Ghiorghiu, Sarah Halford, Andrew Johnston, Rick Kaplan, Anna Lawson, Emma Lowe, Jacqueline Mathews, Ilaria Mirabile, Leeza Osipenko, Dipak Patel, Claire Potter, Aoife Regan, Marivic Ricamara, Carly Ringrose, Joanne Rodger, Gurcharan K. Sandhu, Francesca Schiavone, Julie Silvester, Matthew R. Sydes, Charles Weller & Angeliki Yiangou. (2020) Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement. British Journal of Cancer 122:4, pages 473-482.
Crossref
Crossref
Fang-Shu Ou, Ming-Wen An, Amy S. Ruppert & Sumithra J. Mandrekar. (2019) Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies. JCO Precision Oncology:3, pages 1-10.
Crossref
Crossref
Karolina Strzebonska & Marcin Waligora. (2019) Umbrella and basket trials in oncology: ethical challenges. BMC Medical Ethics 20:1.
Crossref
Crossref
Jennifer Le-Rademacher, Suzanne Dahlberg, J. Jack Lee, Alex A. Adjei & Sumithra J. Mandrekar. (2018) Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations. Journal of Thoracic Oncology 13:11, pages 1625-1637.
Crossref
Crossref